GB9827034D0 - Delivery formulation - Google Patents
Delivery formulationInfo
- Publication number
- GB9827034D0 GB9827034D0 GB9827034A GB9827034A GB9827034D0 GB 9827034 D0 GB9827034 D0 GB 9827034D0 GB 9827034 A GB9827034 A GB 9827034A GB 9827034 A GB9827034 A GB 9827034A GB 9827034 D0 GB9827034 D0 GB 9827034D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- matrix
- dose form
- delivery formulation
- delivered
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Dispersion Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Optics & Photonics (AREA)
- Nanotechnology (AREA)
- Physics & Mathematics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
A delivery formulation for administration to a mucous membrane and which is either mucoadhesive per se or becomes mucoadhesive on contact with a mucous membrane, said formulation comprising a particulate material to be delivered to or across the membrane in a matrix or dose form containing an amphiphilic substance. Prefered formulations in accordance with the invention comprise a matrix or dose form of the amphiphilic substance in a liquid crystal phase, the matrix or dose form incorporating the particulate material to be delivered.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9827034A GB9827034D0 (en) | 1998-12-10 | 1998-12-10 | Delivery formulation |
AU18667/00A AU1866700A (en) | 1998-12-10 | 1999-12-10 | Formulation for delivery of particulate material to mucosal membranes |
PCT/GB1999/004096 WO2000033816A1 (en) | 1998-12-10 | 1999-12-10 | Formulation for delivery of particulate material to mucosal membranes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9827034A GB9827034D0 (en) | 1998-12-10 | 1998-12-10 | Delivery formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9827034D0 true GB9827034D0 (en) | 1999-02-03 |
Family
ID=10843876
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9827034A Ceased GB9827034D0 (en) | 1998-12-10 | 1998-12-10 | Delivery formulation |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU1866700A (en) |
GB (1) | GB9827034D0 (en) |
WO (1) | WO2000033816A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2060259E (en) | 2001-11-01 | 2010-04-26 | Spectrum Pharmaceuticals Inc | Medical compositions for intravesical treatment of bladder cancer |
US8563592B2 (en) | 2001-11-01 | 2013-10-22 | Spectrum Pharmaceuticals, Inc. | Bladder cancer treatment and methods |
KR100533460B1 (en) * | 2002-07-20 | 2005-12-08 | 대화제약 주식회사 | Mucoadhesive composition and formulation for solubilization of insoluble drugs and preparation method thereof |
ES2545454T3 (en) * | 2002-12-10 | 2015-09-11 | Nortec Development Associates, Inc. | Method of preparing biologically active formulations |
US20080305149A1 (en) * | 2007-06-11 | 2008-12-11 | Thomas Hirt | Mucoadhesive vesicles for drug delivery |
WO2012119838A1 (en) * | 2011-03-04 | 2012-09-13 | Unilever Nv | Self-adhesive hard surface cleaning composition |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8310038D0 (en) * | 1983-04-13 | 1983-05-18 | Amersham Int Plc | Technetium-99 labelled tin colloid |
US5143934A (en) * | 1990-11-21 | 1992-09-01 | A/S Dumex (Dumex Ltd.) | Method and composition for controlled delivery of biologically active agents |
SE518578C2 (en) * | 1994-06-15 | 2002-10-29 | Gs Dev Ab | Lipid-based composition |
JP2857741B2 (en) * | 1995-08-31 | 1999-02-17 | 佐賀大学長 | Coated drug-encapsulated crosslinked chitosan composition, method for producing the same, and use as drug sustained release control system |
CA2231273A1 (en) * | 1995-10-12 | 1997-04-17 | Lise Sylvest Nielsen | A pharmaceutical composition for administration of an active substance to or through a skin or mucosal surface |
-
1998
- 1998-12-10 GB GB9827034A patent/GB9827034D0/en not_active Ceased
-
1999
- 1999-12-10 AU AU18667/00A patent/AU1866700A/en not_active Abandoned
- 1999-12-10 WO PCT/GB1999/004096 patent/WO2000033816A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2000033816A1 (en) | 2000-06-15 |
AU1866700A (en) | 2000-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2416383A1 (en) | Solution-, dispersion- or emulsion-producing film dermatics | |
DE69520492T2 (en) | LIQUID MEDICINAL PREPARATIONS CONTAINING THYROID HORMONES | |
EP0458894A4 (en) | Lipid excipient for nasal delivery and topical application. | |
CA2045290A1 (en) | Plaster with a high content of softening ingredients | |
AU6476496A (en) | Novel formulations for transdermal delivery of pergolide | |
TR200100144T2 (en) | Pharmaceutical aerosol formulation | |
GR3033301T3 (en) | Medicament form for the delivery of active substances to wounds | |
ATE286725T1 (en) | NEW ORAL MEDICINAL PREPARATIONS FOR RIVASTIGMINE WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS | |
FI971776A (en) | Compounds and compositions for the administration of active substances | |
MXPA01007411A (en) | Compositions and methods for mucosal delivery. | |
AU7315496A (en) | Delivery of biologically active polypeptides | |
IL108234A0 (en) | Pharmaceutical composition containing galanthamine | |
NZ501950A (en) | Medicinal compositions for application to mucosa | |
ATE353009T1 (en) | PROCESS FOR PREPARING PHARMACEUTICAL COMPOSITIONS FOR USE WITH SOFT GELATIN FORMULATIONS | |
DK0800386T3 (en) | Transdermal system for simultaneous administration of several active substances | |
NZ320237A (en) | Stable pharmaceutical forms of administration containing parathormone | |
GR3019479T3 (en) | Pharmaceutical compositions for transmucosal delivery of peptides. | |
CA2271944A1 (en) | Formulation for electrically assisted delivery of lidocaine and epinephrine | |
ATE173923T1 (en) | ORAL LIQUID MEDICINAL PREPARATION CONTAINING 2-(4-ISOBUTYLPHENYL)PROPIONIC ACID | |
GB9827034D0 (en) | Delivery formulation | |
AU2002215944A1 (en) | Film for active ingredients dermal and transdermal administration | |
CA2294448A1 (en) | Pharmaceutical combination preparations containing erythropoietin and modified haemoglobins | |
WO2000027430A3 (en) | Composition consisting of influenza virus surface proteins and dispensing device | |
SE9403389D0 (en) | Pharmaceutical composition containing derivatives of sex hormones | |
AU2503900A (en) | Sulfated phosphatidylinositols, their preparation and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |